**Core Concept:**

The question is asking about a patient presenting with bleeding manifestations, subconjunctival hemorrhage, and purpuric rash. The investigations reveal abnormal coagulation parameters, such as prolonged prothrombin time, activated partial thromboplastin time, and low fibrinogen levels, along with peripheral smear showing acute myeloblasts leukemia. This combination of findings is associated with a specific clinical entity.

**Why the Correct Answer is Right:**

The correct answer is **D**. The patient's presentation is consistent with a condition known as disseminated intravascular coagulation (DIC). DIC is a severe complication of acute myeloid leukemia (AML), a type of acute leukemia affecting the bone marrow and blood cells.

In AML, there is overproduction of immature white blood cells, which can lead to impaired platelet production and impaired coagulation factors. These abnormalities result in a state of systemic hypercoagulability, leading to the formation of microthrombi (clots) in small blood vessels throughout the body. This leads to widespread bleeding and organ dysfunction.

**Why Each Wrong Option is Incorrect:**

A. **Hemolytic uremic syndrome (HUS)** is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury due to intravascular coagulation and platelet destruction. However, in the given scenario, the patient's hemoglobin (Hb) level is not severely low (6.4 g/dL), and there is no indication of acute kidney injury.

B. **Von Willebrand's disease** is a congenital bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor, which is essential for platelet adhesion and function. The patient's platelet count is not severely low (35,000/mm³), and the bleeding manifestations are not exclusively mucocutaneous (no bleeding from mucous membranes or skin).

C. **Hemolytic uremic syndrome (HUS)** is a distinct entity characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury due to intravascular coagulation and platelet destruction. In the presented case, the patient's hemoglobin (Hb) level is not severely low (6.4 g/dL), and there is no indication of acute kidney injury.

D. **Disseminated intravascular coagulation (DIC)** is the correct answer. In this scenario, the patient exhibits severe anemia (Hb 6.4 g/dL), thrombocytopenia (platelet count 35,000/mm³), and coagulation abnormalities (prothrombin time of 20 seconds and activated partial thromboplastin time of 50 seconds). These findings are consistent with DIC.

**Clinical Pearls:**

1. DIC is a life-threatening condition that occurs in severe underlying diseases like acute leukemia like AML.
2. The presentation of DIC is characterized by systemic bleeding and organ dysfunction due to excessive intravascular coagulation and platelet destruction.
3. Diagnosis of DIC is suggested by the combination of bleeding